Drug Drug Interaction Trial With Strong CYP3A4 Inhibitor (Itraconazole) in CYP2C19 Extensive Metabolizers and Poor Metabolizers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 8, 2014

Primary Completion Date

January 7, 2015

Study Completion Date

January 8, 2015

Conditions

Healthy

Interventions

DRUG

BI 409306

Oral single dose of BI 409306

DRUG

Itraconazole

Oral dose, twice daily on Day -3, once daily on Day -2 to Day 2 of Itraconazole

Trial Locations (1)

1289.23.8201 Boehringer Ingelheim Investigational Site, Seoul